CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue
Diagnostic testing service	$ 525,954	$ 409,118
Product sales	0	223,440
Total revenue	525,954	632,558
Cost of revenue
Diagnostic testing service	340,658	105,764
Product sales	0	239,755
Total cost of revenue	340,658	345,519
Loss on obsolete inventory	0	149,946
Gross profit	185,296	137,093
Selling expenses	1,271,705	1,257,791
Research and development expenses	2,577,465	1,105,110
General and administrative expenses	8,625,917	8,558,835
Impairment of intangible assets	2,352,626	0
Total operating expenses	14,827,713	10,921,736
Operating loss	(14,642,417)	(10,784,643)
Interest income	260	295
Interest expense	(15,769)	(360)
Net loss before income taxes	(14,657,926)	(10,784,708)
Income taxes	0	0
Net loss	$ (14,657,926)	$ (10,784,708)
Loss per common share - basic and diluted (in dollars per share)	$ (0.61)	$ (0.70)
Weighted average shares outstanding, basic & diluted (in shares)	24,038,578	15,484,414